Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9685058 | 0.81 | MEN1 (0.48) | MEN1KMT2A | |
| Propylene Glycol SCHEMBL23524461 | 0.70 | TDP1 (0.53) | MEN1KMT2A | |
| SCHEMBL8961801 | 0.70 | ALDH1A1 (0.38) | MEN1KMT2A | |
| SCHEMBL27861152 | 0.70 | HSD17B10 (0.42) | — | |
| SCHEMBL30880446 | 0.68 | MEN1 (0.38) | MEN1KMT2A | |
| SCHEMBL5081800 | 0.68 | MEN1 (0.38) | MEN1KMT2A | |
| SCHEMBL17006458 | 0.68 | MEN1 (0.38) | MEN1KMT2A | |
| SCHEMBL9749061 | 0.68 | MEN1 (0.38) | MEN1KMT2A | |
| SCHEMBL25256307 | 0.68 | MEN1 (0.38) | MEN1KMT2A | |
| SCHEMBL58951 | 0.68 | MEN1 (0.38) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013174904-A1 | EXHAUST GAS DECARBONATION PROCESS | TOTAL S.A. (FR) | 2013-11-28 | — | — | WO | disclosed |
| US-20090182057-A1 | DEUTERATED AMINOGLYCIDAL COMPOUNDS | AUSPEX PHARMACEUTICALS, INC. (US) | 2009-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090182057-A1 | DEUTERATED AMINOGLYCIDAL COMPOUNDS | ADRB2, GLRB, ADRB1 | MEN1 2002/4885KMT2A 3732/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.